ASX
Telix Pharmaceuticals Limited
TLX:ASX•Healthcare
Sensitive ASX Announcement
First Patient Dosed in Ph III ProstACT GLOBAL Therapy Study
Published: 13/11/23, 08:32am (AEST)•3 pages